A Study of NGM282 in Patients With Primary Sclerosing Cholangitis
Public ClinicalTrials.gov record NCT02704364. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Efficacy of NGM282 Administered for 12 Weeks in Patients With Primary Sclerosing Cholangitis
Study identification
- NCT ID
- NCT02704364
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- NGM Biopharmaceuticals, Inc
- Industry
- Enrollment
- 62 participants
Conditions and interventions
Conditions
Interventions
- NGM282 Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2016
- Primary completion
- May 31, 2017
- Completion
- May 31, 2017
- Last update posted
- Jun 16, 2025
2016 – 2017
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NGM Clinical Study Site 118 | Sacramento | California | — | — |
| NGM Clinical Study Site 112 | San Clemente | California | — | — |
| NGM Clinical Study Site 127 | San Francisco | California | — | — |
| NGM Clinical Study Site 106 | Aurora | Colorado | — | — |
| NGM Clinical Study Site 115 | Washington D.C. | District of Columbia | — | — |
| NGM Clinical Study Site 110 | Gainesville | Florida | — | — |
| NGM Clinical Study Site 124 | Lakewood Rch | Florida | — | — |
| NGM Clinical Study Site 105 | Miami | Florida | — | — |
| NGM Clinical Study Site 109 | Indianapolis | Indiana | — | — |
| NGM Clinical Study Site 104 | Detroit | Michigan | — | — |
| NGM Clinical Study Site 102 | Kansas City | Missouri | — | — |
| NGM Clinical Study Site 107 | St Louis | Missouri | — | — |
| NGM Clinical Study Site 103 | New York | New York | — | — |
| NGM Clinical Study Site 116 | Durham | North Carolina | — | — |
| NGM Clinical Study Site 120 | Cincinnati | Ohio | — | — |
| NGM Clinical Study Site 114 | Nashville | Tennessee | — | — |
| NGM Clinical Study Site 113 | Dallas | Texas | — | — |
| NGM Clinical Study Site 117 | Dallas | Texas | — | — |
| NGM Clinical Study Site 119 | Houston | Texas | — | — |
| NGM Clinical Study Site 125 | Southlake | Texas | — | — |
| NGM Clinical Study Site 111 | Charlottesville | Virginia | — | — |
| NGM Clinical Study Site 122 | Newport News | Virginia | — | — |
| NGM Clinical Study Site 101 | Norfolk | Virginia | — | — |
| NGM Clinical Study Site 121 | Richmond | Virginia | — | — |
| NGM Clinical Study Site 108 | Seattle | Washington | — | — |
| NGM Clinical Study Site 126 | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02704364, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 16, 2025 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02704364 live on ClinicalTrials.gov.